AP Alternative Assets LP AAA NA
October 06, 2013 - 1:53pm EST by
chaney943
2013 2014
Price: 28.50 EPS $0.00 $0.00
Shares Out. (in M): 76 P/E 0.0x 0.0x
Market Cap (in $M): 2,200 P/FCF 0.0x 0.0x
Net Debt (in $M): 0 EBIT 0 0
TEV ($): 0 TEV/EBIT 0.0x 0.0x

Sign up for free guest access to view investment idea with a 45 days delay.

 

Description

AP Alternative Assets – Athene (AAA NA)

We are recommending purchase of AP Alternative (traded in the Netherlands under AAA NA). Despite the Dutch listing, this is entirely a U.S. company. The accounting is in U.S. GAAP, assets are held in U.S. dollars and even the share price is quoted in U.S. dollars. We believe the shares are worth at least $50 today and are trading at only 2.3x ‘normalized’ earnings.

AP Alternative was a public vehicle started in 2006 by Apollo (NYSE: APO) to hold stakes in Apollo private equity deals and funds. The structure at that time required a Dutch listing. The shares languished and consistently traded well below the fund’s stated Net Asset Value. The fund’s largest investment was in Athene, another company started by Apollo to purchase blocks of fixed annuities. In 2013, AP Alternative (AAA) traded its investment portfolio (Realogy, Rexnord, Smart & Final, Norwegian Cruise Lines, etc.) for a larger stake in Athene and now AAA basically has one asset: 73% of Athene.

Athene announced this week the closing of a transformative deal for Aviva’s U.S. life insurance business. Athene and Apollo have been incredibly tight-lipped about pro forma numbers, even by Apollo standards. We think this is because management likely does not want to parade high levels of profitability at the same time they were seeking deal approval from regulators (NY, the biggest and last hurdle struck an agreement to allow the deal in late summer).

Catalysts:

1) Closing of Aviva USA deal this week, 2) highlighting of pro forma financials, including $5B of statutory capital (vs $1.9B of last published GAAP BV at June 30) and $60B of assets (vs $15B of last reported assets) – all increased with minimal dilution to AAA, 3) analyst day that will highlight these metrics, which was promised this summer, but pushed back to late 2013/ early 2014, 4) coming IPO of direct comparable Fidelity & Guaranty, likely at twice AAA’s current multiple,  5) merger of AAA with Athene and re-listing from the Netherlands to the US, likely in 2014, but required by 2015 and 6) sellside analyst coverage concurrent with the US listing or earlier.

Here are the basic financials we have on Athene/AAA @ June 30:

Athene/AAA @ June 30, 2013

Athene Assets: $14.8B

Athene GAAP Equity: $1.9B (ex-AOCI)

AAA owns 73% of Athene valued at 1.2x equity and has 76m shares outstanding

AAA NAV: $21.67 / share ($1.9B x 1.2 multiple of equity x 73% ownership / 76m shares)

Here are the basic financials we have on Athene/AAA on a pro forma basis. This data is taken from company presentations, conference calls, and websites (some of which are no longer published):

Athene/AAA Pro Forma for Aviva USA Before APO Performance Allocation:

Athene Assets: $60B (Athene’s current stated assets of $15B + Aviva USA has $57.5B but $10B of life assets will be sold to Global Atlantic, a Goldman entity)

Athene Statutory Capital: $5B – from previously published website and confirmed by investor relations

When I asked AAA investor relations to bridge the gap between current stated GAAP equity of $1.9B to pro forma statutory capital of $5B, they said the main difference was that the Aviva book was being purchased at such a significant discount to stated book that the difference was the gain from the mark. GAAP recognizes similar gains so our best estimate of pro forma GAAP book value is $5B as well. Note: that the $5B of statutory capital has been previously published on Athene websites, but has recently been removed. However, additional ways to confirm this are that their stated leverage ratio is 10 to 12x so $60B of assets on $5B of statutory capital meets their leverage target. $60B of assets on their current $1.9B of stated GAAP equity value would be 32x leverage and probably unacceptable to regulators.

If we are correct that GAAP book value will approximate statutory then:

AAA owns 73% valued at 1.2x with 76m shares ($5B x 1.2x x 73% / 76m shares)

Pro-forma AAA NAV: $57.60 (97% above today’s stock price).

AAA NAV After APO Carried Interest:

APO receives 20% of realized gains on AAA’s ‘Opportunistic Investments’ which is now only Athene. Management fees and carried interest can be payable either in cash or in shares of Athene valued at the current fair market value. We believe the most likely scenario is that Athene will go public in 2014, Apollo (APO) will receive their carried interest paid in Athene stock at the IPO price and AAA will be discontinue/rolled up into Athene. Our assumptions for each of these adjustments are as follows. Statutory book value will be $5 billion, the IPO valuation ill be 1.2x statutory book value for a total market capitalization of $6B. Apollo (APO) will receive a performance fee paid in increased ownership of Athene equal to 12% of Athene, thus AAA’s ownership is reduced to 64%. Finally, AAA has agreed that their management contract with Apollo (APO) can be bought out for $30m in 2013, $25m in 2014, $20m in 2015, and zero thereafter. Exhibit 1 below combines each of these adjustments to estimate AAA’s NAV assuming a 2014 IPO of Athene at 1.2x statutory book value.

 

 

Exhibit 1.

AAA Book Value Assuming a 2014 IPO of Athene at 1.2x Book

($ in millions)

 

BV @ June 30 (ex-AOCI):                                               $1,900              from Athene presentation

Estimated Market Value Multiple on book                 1.2x       From AAA presentation

Estimated Market Value @ June 30                   $2,280

Proforma BV Today1                                                       $5,000              From Athene website

Estimated Market Value Multiple of Book                   1.2x       We use the same multiple of book

Equity Value of Athene                                                $6,000

APO’s 20% Allocation:                                                     ($744)            $6B FMV today less $2.3B FMV @ 6/30 x 20%

APO’s Allocation % of Athene Value                              12%          $744m / $6B

AAA’s Pro Forma Ownership                                               64%          73% diluted by 12%

AAA’s NAV With Mgt Contract                                 $3,837              64% of $6B

Cost to Terminate Mgt Contract                                 ($25)            We expect AAA to terminate the contract

AAA’s NAV after Contract Termination             $3,812

AAA’s Current Shares Outstanding                                76m

AAA Estimated NAV                                                          $50.16

 

 

Cross Check Using Earnings Based Approach:

AAA has historically valued their Athene investment at 1.2x GAAP book value ex-AOCI so they must expect that the company will be reasonably profitable to justify a premium to book. In past presentations, they have presented investors with the following model:

Yield/Investment Returns: 6%

Cost of Funds: 3%

NIM: 3%

SG&A: 0.50%

Pretax ROA: 2.5%

Leverage: 10x – 12x

ROE: 25% - 30%

Note: Athene is domiciled in Bermuda so pretax ROE = aftertax ROE

Athene’s 1H13 ROE was 27% despite only 7x leverage vs 10 to 12x leverage target. This included gains on PE investments, but with the new portfolio composition, some level of PE gains will be recurring.

For an insurance company, their leverage is limited by statutory capital, not GAAP so really with this earnings based approach we don’t need to worry about bridging the difference between statutory and GAAP book values.

Assets: $60B x 2.5% ROA = $1.5B of earnings or $14.21/share. On a proforma basis including the Athene ownership dilution from carried interest, EPS would be $12.62/share (assumes APO’s Athene ownership increases 12% for carried interest). See Exhibit 2.

Exhibit 2.

AAA Illustrative ‘Normalized’ Earnings

 

Assets1                                                                         $60,000

ROA %                                                                       2.5%

Net Income                                             $1,500

AAA’s Ownership interest                       73%

AAA’s % of Net Income                    $1,095

Current AAA Shares Out:                          76

Normalized AAA EPS:                               $14.41

Implied PE (x)                                                      2.0x

 

After APO Carried Interest                           

AAA’s Ownership interest                       64%

AAA’s % of Net Income                         $960

Normalized AAA EPS                                $12.63

Implied PE (x)                                                      2.3x

 

Avg Life Insurance P/E                                   9.0x

AAA Price @ Avg Multiple                $113.68

 

The company emphasizes this is their long-term model, not day 1 returns. But if we view this as ‘normalized earnings’, Athene will make $1.5B of earnings. AAA owns 73% of Athene’s earnings which will be $1.1B or $14.41/share. If we assume APO received their 20% performance allocation in increased Athene ownership, EPS would be $12.63. What’s the lowest P/E multiple we could apply – maybe 6x – then it’s a $76 stock! At a life insurance average multiple of 9x – it’s a $114 stock!

How Can APO Make Aviva USA Business So Much More Profitable?

The obvious question is: if the Aviva USA business is so valuable, why would they sell it for such a discount to book value? From speaking with insurance industry insiders, we found that the biggest answer is Bermuda. Bermuda has lower taxes, lower capital requirements and increased investment “flexibility”. From a Dupont model perspective – Bermuda increases both ROA (lower taxes and investment flexibility) and leverage (lower capital requirements) to get to a higher ROE business. It also probably doesn’t hurt that that deal with Aviva was announced in December 2012 when the 10-year yield was 1.76% (vs. 2.63% today), ‘taper’ was not yet in our vocabulary and ‘normalized earnings’ was nothing more than a dream. Since the deal was announced, other rate plays such as Schwab and Ameritrade are up 49% and 58% respectively while the larger life insurance companies are up 40-65%.

Coming IPO of Fidelity & Guaranty Life

Fidelity & Guaranty Life filed to go public in August. F&G is a leading provider of fixed indexed annuities and should be a direct comparable to Athene. Credit Suisse is the lead manager and we believe timing is later this year. From our review of the financials and from speaking with institutional investors in insurance, we believe this company will IPO at 1.0x book or higher. This should be a good comparable for Athene, should increase investor awareness in the space and highlight Athene’s relative undervaluation. More about this IPO can be read from the following link:

http://www.lifehealthpro.com/2013/08/29/harbinger-files-for-100m-ipo-of-fidelity-guaranty

Valuation

The valuation metrics used for our AAA analysis are reasonable when compared to publicly listed life insurers, annuity writers, the previously mentioned expected sponsor-owned life insurance IPO; and when compared to historical life insurance averages. See Exhibit 3, 4.

Exhibit 3.

AAA Comparable Valuation Matrix

 

                                                                           2014                                                         Price /

                                                           PE (x)       P/B (x)                                       Statutory Book2

Life Insurance median           9.0x                               1.00x

     LNC                                                 8.0x                               0.87x                                                       1.65x

     AEL                                                  9.5x                               1.10x                                                       0.80x

     PL                                                    9.3x                               1.15x                                                       1.10x

                                                                                                                                                                  Assumed

Fidelity & Guaranty Life1                                                                                                         IPO Multiple

     GAAP Book Value (ex AOCI)                               $1,110                                                   1.1x – 1.2x

     Statutory Book value                                           $1,167

 

 (1) Assume IPO out of Harbinger Group (HRG); timing uncertain.

 (2) Statutory book calculated using capital & surplus from NAIC filings

 

Note: LNC, AEL, PL have significant fixed and indexed annuity exposure.

 

Management

Athene is run by Jim Belardi, formerly a senior executive at Sunlife (which was ultimately purchased at 5x book). Jim is considered top notch in the life insurance industry and Athene is probably the best management team of the companies that have been pursuing the fixed annuity block business. We suggest “Googling” Mr. Belardi as there are numerous articles on him that do a much better job chronicling his career than we can do here. We also confirmed that he is well respected by life insurance executives and investment analysts.

 

I do not hold a position of employment, directorship, or consultancy with the issuer.
I and/or others I advise hold a material investment in the issuer's securities.

Catalyst

 

1) Closing of Aviva USA deal this week, 2) highlighting of pro forma financials, including $5B of statutory capital (vs $1.9B of last published GAAP BV at June 30) and $60B of assets (vs $15B of last reported assets) – all increased with minimal dilution to AAA, 3) analyst day that will highlight these metrics, which was promised this summer, but pushed back to late 2013/ early 2014, 4) coming IPO of direct comparable Fidelity & Guaranty, likely at twice AAA’s current multiple,  5) merger of AAA with Athene and re-listing from the Netherlands to the US, likely in 2014, but required by 2015 and 6) sellside analyst coverage concurrent with the US listing or earlier.

    sort by    

    Description

    AP Alternative Assets – Athene (AAA NA)

    We are recommending purchase of AP Alternative (traded in the Netherlands under AAA NA). Despite the Dutch listing, this is entirely a U.S. company. The accounting is in U.S. GAAP, assets are held in U.S. dollars and even the share price is quoted in U.S. dollars. We believe the shares are worth at least $50 today and are trading at only 2.3x ‘normalized’ earnings.

    AP Alternative was a public vehicle started in 2006 by Apollo (NYSE: APO) to hold stakes in Apollo private equity deals and funds. The structure at that time required a Dutch listing. The shares languished and consistently traded well below the fund’s stated Net Asset Value. The fund’s largest investment was in Athene, another company started by Apollo to purchase blocks of fixed annuities. In 2013, AP Alternative (AAA) traded its investment portfolio (Realogy, Rexnord, Smart & Final, Norwegian Cruise Lines, etc.) for a larger stake in Athene and now AAA basically has one asset: 73% of Athene.

    Athene announced this week the closing of a transformative deal for Aviva’s U.S. life insurance business. Athene and Apollo have been incredibly tight-lipped about pro forma numbers, even by Apollo standards. We think this is because management likely does not want to parade high levels of profitability at the same time they were seeking deal approval from regulators (NY, the biggest and last hurdle struck an agreement to allow the deal in late summer).

    Catalysts:

    1) Closing of Aviva USA deal this week, 2) highlighting of pro forma financials, including $5B of statutory capital (vs $1.9B of last published GAAP BV at June 30) and $60B of assets (vs $15B of last reported assets) – all increased with minimal dilution to AAA, 3) analyst day that will highlight these metrics, which was promised this summer, but pushed back to late 2013/ early 2014, 4) coming IPO of direct comparable Fidelity & Guaranty, likely at twice AAA’s current multiple,  5) merger of AAA with Athene and re-listing from the Netherlands to the US, likely in 2014, but required by 2015 and 6) sellside analyst coverage concurrent with the US listing or earlier.

    Here are the basic financials we have on Athene/AAA @ June 30:

    Athene/AAA @ June 30, 2013

    Athene Assets: $14.8B

    Athene GAAP Equity: $1.9B (ex-AOCI)

    AAA owns 73% of Athene valued at 1.2x equity and has 76m shares outstanding

    AAA NAV: $21.67 / share ($1.9B x 1.2 multiple of equity x 73% ownership / 76m shares)

    Here are the basic financials we have on Athene/AAA on a pro forma basis. This data is taken from company presentations, conference calls, and websites (some of which are no longer published):

    Athene/AAA Pro Forma for Aviva USA Before APO Performance Allocation:

    Athene Assets: $60B (Athene’s current stated assets of $15B + Aviva USA has $57.5B but $10B of life assets will be sold to Global Atlantic, a Goldman entity)

    Athene Statutory Capital: $5B – from previously published website and confirmed by investor relations

    When I asked AAA investor relations to bridge the gap between current stated GAAP equity of $1.9B to pro forma statutory capital of $5B, they said the main difference was that the Aviva book was being purchased at such a significant discount to stated book that the difference was the gain from the mark. GAAP recognizes similar gains so our best estimate of pro forma GAAP book value is $5B as well. Note: that the $5B of statutory capital has been previously published on Athene websites, but has recently been removed. However, additional ways to confirm this are that their stated leverage ratio is 10 to 12x so $60B of assets on $5B of statutory capital meets their leverage target. $60B of assets on their current $1.9B of stated GAAP equity value would be 32x leverage and probably unacceptable to regulators.

    If we are correct that GAAP book value will approximate statutory then:

    AAA owns 73% valued at 1.2x with 76m shares ($5B x 1.2x x 73% / 76m shares)

    Pro-forma AAA NAV: $57.60 (97% above today’s stock price).

    AAA NAV After APO Carried Interest:

    APO receives 20% of realized gains on AAA’s ‘Opportunistic Investments’ which is now only Athene. Management fees and carried interest can be payable either in cash or in shares of Athene valued at the current fair market value. We believe the most likely scenario is that Athene will go public in 2014, Apollo (APO) will receive their carried interest paid in Athene stock at the IPO price and AAA will be discontinue/rolled up into Athene. Our assumptions for each of these adjustments are as follows. Statutory book value will be $5 billion, the IPO valuation ill be 1.2x statutory book value for a total market capitalization of $6B. Apollo (APO) will receive a performance fee paid in increased ownership of Athene equal to 12% of Athene, thus AAA’s ownership is reduced to 64%. Finally, AAA has agreed that their management contract with Apollo (APO) can be bought out for $30m in 2013, $25m in 2014, $20m in 2015, and zero thereafter. Exhibit 1 below combines each of these adjustments to estimate AAA’s NAV assuming a 2014 IPO of Athene at 1.2x statutory book value.

     

     

    Exhibit 1.

    AAA Book Value Assuming a 2014 IPO of Athene at 1.2x Book

    ($ in millions)

     

    BV @ June 30 (ex-AOCI):                                               $1,900              from Athene presentation

    Estimated Market Value Multiple on book                 1.2x       From AAA presentation

    Estimated Market Value @ June 30                   $2,280

    Proforma BV Today1                                                       $5,000              From Athene website

    Estimated Market Value Multiple of Book                   1.2x       We use the same multiple of book

    Equity Value of Athene                                                $6,000

    APO’s 20% Allocation:                                                     ($744)            $6B FMV today less $2.3B FMV @ 6/30 x 20%

    APO’s Allocation % of Athene Value                              12%          $744m / $6B

    AAA’s Pro Forma Ownership                                               64%          73% diluted by 12%

    AAA’s NAV With Mgt Contract                                 $3,837              64% of $6B

    Cost to Terminate Mgt Contract                                 ($25)            We expect AAA to terminate the contract

    AAA’s NAV after Contract Termination             $3,812

    AAA’s Current Shares Outstanding                                76m

    AAA Estimated NAV                                                          $50.16

     

     

    Cross Check Using Earnings Based Approach:

    AAA has historically valued their Athene investment at 1.2x GAAP book value ex-AOCI so they must expect that the company will be reasonably profitable to justify a premium to book. In past presentations, they have presented investors with the following model:

    Yield/Investment Returns: 6%

    Cost of Funds: 3%

    NIM: 3%

    SG&A: 0.50%

    Pretax ROA: 2.5%

    Leverage: 10x – 12x

    ROE: 25% - 30%

    Note: Athene is domiciled in Bermuda so pretax ROE = aftertax ROE

    Athene’s 1H13 ROE was 27% despite only 7x leverage vs 10 to 12x leverage target. This included gains on PE investments, but with the new portfolio composition, some level of PE gains will be recurring.

    For an insurance company, their leverage is limited by statutory capital, not GAAP so really with this earnings based approach we don’t need to worry about bridging the difference between statutory and GAAP book values.

    Assets: $60B x 2.5% ROA = $1.5B of earnings or $14.21/share. On a proforma basis including the Athene ownership dilution from carried interest, EPS would be $12.62/share (assumes APO’s Athene ownership increases 12% for carried interest). See Exhibit 2.

    Exhibit 2.

    AAA Illustrative ‘Normalized’ Earnings

     

    Assets1                                                                         $60,000

    ROA %                                                                       2.5%

    Net Income                                             $1,500

    AAA’s Ownership interest                       73%

    AAA’s % of Net Income                    $1,095

    Current AAA Shares Out:                          76

    Normalized AAA EPS:                               $14.41

    Implied PE (x)                                                      2.0x

     

    After APO Carried Interest                           

    AAA’s Ownership interest                       64%

    AAA’s % of Net Income                         $960

    Normalized AAA EPS                                $12.63

    Implied PE (x)                                                      2.3x

     

    Avg Life Insurance P/E                                   9.0x

    AAA Price @ Avg Multiple                $113.68

     

    The company emphasizes this is their long-term model, not day 1 returns. But if we view this as ‘normalized earnings’, Athene will make $1.5B of earnings. AAA owns 73% of Athene’s earnings which will be $1.1B or $14.41/share. If we assume APO received their 20% performance allocation in increased Athene ownership, EPS would be $12.63. What’s the lowest P/E multiple we could apply – maybe 6x – then it’s a $76 stock! At a life insurance average multiple of 9x – it’s a $114 stock!

    How Can APO Make Aviva USA Business So Much More Profitable?

    The obvious question is: if the Aviva USA business is so valuable, why would they sell it for such a discount to book value? From speaking with insurance industry insiders, we found that the biggest answer is Bermuda. Bermuda has lower taxes, lower capital requirements and increased investment “flexibility”. From a Dupont model perspective – Bermuda increases both ROA (lower taxes and investment flexibility) and leverage (lower capital requirements) to get to a higher ROE business. It also probably doesn’t hurt that that deal with Aviva was announced in December 2012 when the 10-year yield was 1.76% (vs. 2.63% today), ‘taper’ was not yet in our vocabulary and ‘normalized earnings’ was nothing more than a dream. Since the deal was announced, other rate plays such as Schwab and Ameritrade are up 49% and 58% respectively while the larger life insurance companies are up 40-65%.

    Coming IPO of Fidelity & Guaranty Life

    Fidelity & Guaranty Life filed to go public in August. F&G is a leading provider of fixed indexed annuities and should be a direct comparable to Athene. Credit Suisse is the lead manager and we believe timing is later this year. From our review of the financials and from speaking with institutional investors in insurance, we believe this company will IPO at 1.0x book or higher. This should be a good comparable for Athene, should increase investor awareness in the space and highlight Athene’s relative undervaluation. More about this IPO can be read from the following link:

    http://www.lifehealthpro.com/2013/08/29/harbinger-files-for-100m-ipo-of-fidelity-guaranty

    Valuation

    The valuation metrics used for our AAA analysis are reasonable when compared to publicly listed life insurers, annuity writers, the previously mentioned expected sponsor-owned life insurance IPO; and when compared to historical life insurance averages. See Exhibit 3, 4.

    Exhibit 3.

    AAA Comparable Valuation Matrix

     

                                                                               2014                                                         Price /

                                                               PE (x)       P/B (x)                                       Statutory Book2

    Life Insurance median           9.0x                               1.00x

         LNC                                                 8.0x                               0.87x                                                       1.65x

         AEL                                                  9.5x                               1.10x                                                       0.80x

         PL                                                    9.3x                               1.15x                                                       1.10x

                                                                                                                                                                      Assumed

    Fidelity & Guaranty Life1                                                                                                         IPO Multiple

         GAAP Book Value (ex AOCI)                               $1,110                                                   1.1x – 1.2x

         Statutory Book value                                           $1,167

     

     (1) Assume IPO out of Harbinger Group (HRG); timing uncertain.

     (2) Statutory book calculated using capital & surplus from NAIC filings

     

    Note: LNC, AEL, PL have significant fixed and indexed annuity exposure.

     

    Management

    Athene is run by Jim Belardi, formerly a senior executive at Sunlife (which was ultimately purchased at 5x book). Jim is considered top notch in the life insurance industry and Athene is probably the best management team of the companies that have been pursuing the fixed annuity block business. We suggest “Googling” Mr. Belardi as there are numerous articles on him that do a much better job chronicling his career than we can do here. We also confirmed that he is well respected by life insurance executives and investment analysts.

     

    I do not hold a position of employment, directorship, or consultancy with the issuer.
    I and/or others I advise hold a material investment in the issuer's securities.

    Catalyst

     

    1) Closing of Aviva USA deal this week, 2) highlighting of pro forma financials, including $5B of statutory capital (vs $1.9B of last published GAAP BV at June 30) and $60B of assets (vs $15B of last reported assets) – all increased with minimal dilution to AAA, 3) analyst day that will highlight these metrics, which was promised this summer, but pushed back to late 2013/ early 2014, 4) coming IPO of direct comparable Fidelity & Guaranty, likely at twice AAA’s current multiple,  5) merger of AAA with Athene and re-listing from the Netherlands to the US, likely in 2014, but required by 2015 and 6) sellside analyst coverage concurrent with the US listing or earlier.

    Messages


    Subject$5B?
    Entry10/07/2013 09:40 AM
    Membercfavenger
    Thanks for the writeup.
     
    Do you have the document where they cited the $5B combined statutory book value of the combined entity?  
     
    If they have taken it down and/or you no longer have it, do you know which document it was in?
     
    I don't recall ever seeing a pro forma number that high but may have missed it.

    Subject$5B - follow up
    Entry10/07/2013 09:44 AM
    Membercfavenger
    Just checking ... are you sure you adjusted the combined book value of the pro forma entity for the $1.5B purchase price of Aviva?  I could easily have missed something but my own calculations don't reconcile to yours and I'm trying to bridge the gap.
     
     

    SubjectRE: $5B?
    Entry10/07/2013 11:46 AM
    Memberchaney943
    We found the proforma equity value on the company's website, www.athene.com - on the home page & vetted with IR. Subsequent to our questions, the # and sentence were removed from the website. When we questioned IR on this change, we were told they "updated disclosures in their presentation", although there was no pro-forma equity value published.
    Additionally, we think 10-12x stated leverage on $60bn of assets implies approximately $5bn of equity, and would be acceptable to regulators.
     

    SubjectRE: RE: $5B?
    Entry10/07/2013 12:19 PM
    Membercfavenger
    Thanks.  Have you been able to get anywhere near the $5B bottom up beyond what IR says it is though?
     
    You say Athene pre-deal book is 1.9B.  The last numbers I saw in an AAA presentation showed Aviva statutory book of 2.7B.  That gets you to 4.6B.  But they are paying 1.55B for Aviva which gets you back closer to $3B than $5B before adjusting for AAA's stake in Aviva/Apollos fees/etc...  Numbers may have moved around a bit at Aviva but I doubt stat book there doubled in the past few months.  
     
    When they said $5B pro-forma was the phrasing something like "Athene and Aviva together have $5B in statutory capital" or "pro forma for the deal we will have $5B in statutory capital."  The first kind of phrasing might imply the $5B is before Athene pays for Aviva which would mostly reconcile our numbers.  In the second case I'm just confused.  

    Re: your backing into the $5B via leverage calculations, is it possible something occured like borrowing at a holdco level and placing that capital in a subsidiary which would satistfy statutory leverage ratios with only $3B of GAAP equity?  They could also have tapped the life reinsurers for capital support.  I know that unfortunately AAA has been very tight lipped about explaining the deal which makes it hard to figure this stuff.
     
     

    SubjectRE: RE: RE: $5B?
    Entry10/07/2013 02:40 PM
    Memberchaney943
    We read it as "proforma" - post the acquisition.

    SubjectROAs
    Entry10/08/2013 03:11 PM
    Membercompass868
    i like this idea.  i had a question on the ROAs.  I find their presentation a little confusing.  Im referring to slide 12 of the February presentation..."high level business model overview".  i believe this is the source you are referencing the target ROAs from, if I'm mistaken, please advise.  At the top of the slide they illustrate a range of outcomes/targets which would seem to indicate a range of pretax/after tax ROAs of 1-3%.  Then on the bottom of the slide they seem to suggest a net ROA of around 1% (the 2.50% emboldended less the 1.5%).  So it seems like the slide suggests two different targets...i must be missing something.  Any thoughts? And where do you get 2.5%? thanks
    compass 

    SubjectRE: RE: RE: RE: RE: $5B?
    Entry10/08/2013 05:58 PM
    Memberchaney943
    I'm just using the model the company has used in past presentations as their long-term model. Maybe they never hit these numbers, but current price certainly does not reflects them ever hitting theses numbers

    SubjectRE: ROAs
    Entry10/10/2013 12:11 PM
    Memberchaney943
    I just reviewed the slide 12 from the February presentation (sorry for the delay). 
     
    The 2.5% ROA that I used is my write up was from earlier converstations I had with management about the Athene business model and is generally consisent with the top part of this slide that shows a ROA range of 1.0 to 3.0%. What I like best about this idea is even if we assume the low part of the range of 1.0% - there is still tremendous upside to AAA.
     
    The bottom left part of that slide is taking the low end of the ROA range (appears to be using 1.4% - $20 / $1,500 or $16 / $1,100) and showing the implied ROE. If are anywhere close to right and the low end of their range is a 1.45% ROA and a 16 to 20% ROE then shares should trade at a premium to book. If we just take the low end of their guidance of a 16% ROE and cosnervatively assume shares only trade at book - that's still $20 of upside to the shares.
     
    The bottom right part of the slide I don't follow. They seem to be hitting profitability twise for reserve so I don't follow that. I also don't understand why they dont' tie the numbers down a a ROA or ROE numbers.

    SubjectRE: RE: ROAs
    Entry10/11/2013 12:48 PM
    Membercompass868
    agreed...just to split the difference if we just take the midpoint of their range, so call it 2%, its implies massive eps power as you say...but either way if any of the numbers actually bear fruit (which by the way they have been in the 1h of the year and conceivably should be easier given a tick up in yields in the 2h and beyond), it seems quite cheap.
      Back to top